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 Preface  
 
 The Falk Symposium No 168 which took place in Madrid from March 27th 
to March 28th was entitled ‘IBD in Different Age Groups’. It was the first 
meeting of its kind that was planned to bring together adult and pediatric 
gastroenterologists that are interested in the field of inflammatory bowel dis-
eases. The success of the meeting was overwhelming; the number of attending 
physicians was one of the highest in the history of the Falk meetings. 
 During the meeting, we learned that the incidence in children is not rising 
more as compared with adults; however, the total number of children with 
IBD is increasing. Subsequently, more young patients will have to make the 
transition from a pediatric to an adult gastroenterologist. Therefore, the need 
for an improvement of the interaction of both disciplines is evident.
 The increasing number of very young patients is associated with all prob-
lems inherent to physical and mental development. We face a situation where 
risk factors and response to therapy may be different as the life of these pa-
tients goes by. Therefore, it was important that for the first time an IBD sym-
posium took into account not only the potential differences in phenotypes 
and clinical evolution in IBD along life, but also the changes in environmen-
tal factors and the possible differences in the response of the host to them.
 In fact, there were a lot of issues in which both adults and pediatric gastro-
enterologists learned from each other. The scientific committee tried to put 
together a number of specialists able to explain the differences in the patho-
genesis, clinical manifestations and evolution and therapeutic approaches in 
order to obtain the greatest benefits, the lowest rate of unwanted effects and 
the best quality of life for these patients.
 The presentations held at the 168th Falk meeting have been summarized 
in the papers collected in this issue. The scientific committee and the orga-
nizers hope that all readers will benefit as much as the audience during the 
meeting.
 Gerhard Rogler 
for the members of the Scientific Committee 
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